The association between antipsychotic agents and the risk of myocardial infarction: a systematic review
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • An unfavourable risk profile for myocardial infarction (MI) is associated with various lifestyle factors and co‐morbidities that are more prevalent among patients with severe mental illness. • Patient populations that are prescribed antipsychotic agents have a higher cardiovascular mortality rate than the general population. • The association between the use of antipsychotic agents and any increase in the risk of MI is unclear. WHAT THIS STUDY ADDS • The aim of this systematic literature review was to assess the relationship between antipsychotic agents and MI. • Substantial clinical and methodological heterogeneity between the five studies in this review led to an inconclusive answer to the question whether the use of antipsychotics is associated with the incidence of MI in adults. • The largest study had a favourable internal validity compared with the other studies and did not find an association between the use of antipsychotic agents and an increased risk of MI. AIM Patient populations that are prescribed antipsychotic agents have higher cardiovascular mortality rates. The risk of myocardial infarction is influenced by various factors that are more prevalent in patients with a mental illness. The aim of this review was to determine whether the use of antipsychotic agents is associated with the incidence of myocardial infarction in adults. METHODS Using multiple sources, all studies of antipsychotic agents using myocardial infarction as primary or secondary outcome measures were considered for inclusion. Study populations were adult subjects who had been prescribed an antipsychotic agent at least once in their medical history. RESULTS It total, five studies were identified. Four studies with small numbers of events reported a moderate to strong effect of typical antipsychotic agents on the risk of myocardial infarction. The largest study had a favourable internal validity compared with all other studies and reported no association between the risk of myocardial infarction and current use of either atypical (relative risk 0.98, 95% confidence interval [CI] 0.88, 1.09) or typical antipsychotic agents (relative risk 0.99, 95% CI 0.96, 1.03). CONCLUSION Clinical and methodological heterogeneity between the studies in this review led to an inconclusive answer to the question whether the use of antipsychotics is associated with the incidence of myocardial infarction in adults. Whilst results conflicted, the largest study did not find an association between the use of antipsychotic agents and an increased risk of myocardial infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Excess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120 · cited 1×
“The excess mortality in these patient groups can partly be attributed to a two-fold higher cardiovascular death rate [1, 4–6].”
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
Excess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679
Pratt, L. A., Ford, D. E., Crum, R. M., Armenian, H. K., Gallo, J. J., & Eaton, W. W. (1996) · Circulation · doi:10.1161/01.cir.94.12.3123 · Cited by 643 · cited 7×
“[21].”
InfluentialOsborn, D. P. J., Levy, G., Nazareth, I., Petersen, I., Islam, A., & King, M. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.242 · Cited by 608
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Schizophrenia, neuroleptic medication and mortality
Joukamaa, M., Heliövaara, M., Knekt, P., Aromaa, A., Raitasalo, R., & Lehtinen, V. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.2.122 · Cited by 395 · cited 1×
“The association between the use of antipsychotic agents and any increase in cardiovascular morbidity or mortality is unclear,with some studies reporting increased risks for patients prescribed high doses of antipsychotics whilst other studies have found no such association [3, 17, 18].”
Medical comorbidity in women and men with schizophrenia: A population-based controlled study
Carney, C. P., Jones, L., & Woolson, R. F. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00563.x · Cited by 343
Hennessy, S., Bilker, W. B., Knauss, J. S., Margolis, D. J., Kimmel, S. E., Reynolds, R. F., Glasser, D. B., Morrison, M. F., & Strom, B. L. (2002) · BMJ · doi:10.1136/bmj.325.7372.1070 · Cited by 261 · cited 1×
“Observational studies using administrative data of patients who are prescribed antipsychotic agents have found a two-fold increase in risk of ventricular arrhythmias compared with patient populations not taking antipsychotic agents [25, 26].”
Cited by
Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820
“Few studies have looked at the association between antipsychotics and myocardial infarction, which remains controversial because of heterogeneous clinical settings and methodological approaches (108,109).”
BackgroundGoldstein, B. I., Carnethon, M. R., Matthews, K. A., McIntyre, R. S., Miller, G. E., Raghuveer, G., Stoney, C. M., Wasiak, H., & McCrindle, B. W. (2015) · Circulation · doi:10.1161/cir.0000000000000229 · Cited by 519
“There is no doubt these are undesirable side effects in a population with increased risk of CVD; however, it is important to acknowledge that despite the clear evidence regarding CVD risk factors, evidence that these medications cause increases in CVD or CVD mortality is lacking to date.(231,252) Reasons for this disc…”
ResultCorrell, C. U., Joffe, B. I., Rosen, L. M., Sullivan, T. B., & Joffe, R. T. (2015) · World Psychiatry · doi:10.1002/wps.20187 · Cited by 102
Zivkovic, S., Koh, C. H., Kaza, N., & Jackson, C. A. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2177-5 · Cited by 65
The toxicology and comorbidities of fatal cases involving quetiapine
Pilgrim, J. L., & Drummer, O. H. (2013) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-012-9404-4 · Cited by 32
“The association of antipsychotic drugs such as quetiapine and heart disease, regardless of age, has been strongly supported in the literature [1, 19–23].”
Result
Metadata
- Authors
- Brauer, R., Douglas, I., & Smeeth, L.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2011-11-09
- Volume
- 72
- Issue
- 6
- Pages
- 871-878
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1557703628
- Cited by
- 41
- References
- 12
- FWCI
- 0.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The association between antipsychotic agents and the risk of myocardial infarction: a systematic review. https://app.cochat.ai/papers/10.1111/j.1365-2125.2011.04043.x
- The paper
- Brauer, R., Douglas, I., & Smeeth, L. (2011). The association between antipsychotic agents and the risk of myocardial infarction: a systematic review. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2011.04043.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.